Efficacy of vinorelbine-based neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis of randomized controlled trials

By            

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1145-1151

Science Publishers

Access to resources Recommend Favorite

Adding hormonal therapy to chemotherapy and trastuzumab improves prognosis in patients with hormone receptor-positive and human epidermal growth factor receptor 2-positive primary breast cancer

By Hayashi Naoki  

Breast Cancer Research and Treatment, Vol. 137, Iss. 2, 2013-01 ,pp. : 523-531

Springer Publishing Company

Access to resources Recommend Favorite

Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumab

By                      

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1109-1112

Science Publishers

Access to resources Recommend Favorite

Anthocyanins potentiate the activity of trastuzumab in human epidermal growth factor receptor 2positive breast cancer cells in vitro and in vivo

By              

Molecular Medicine Reports, Vol. 10, Iss. 4, 2014-01 ,pp. : 1921-1926

Spandidos Publications

Access to resources Recommend Favorite

A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases

By Lin Nancy   Freedman Rachel   Ramakrishna Naren   Younger Jerry   Storniolo Anna   Bellon Jennifer   Come Steven   Gelman Rebecca   Harris Gordon   Henderson Mark   MacDonald Shannon   Mahadevan Anand   Eisenberg Emily   Ligibel Jennifer   Mayer Erica   Moy Beverly   Eichler April   Winer Eric  

Breast Cancer Research and Treatment, Vol. 142, Iss. 2, 2013-11 ,pp. : 405-414

Springer Publishing Company

Access to resources Recommend Favorite